Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
Spanish PM Sanchez calls snap election for November 29
Hundreds of French schools stay closed ahead of nationwide day of student protests
Thousands of Imran Khan supporters start march to Pakistani capital, party says
US removes bombers from UK base at centre of suspected Iranian plot
Omani court sentences two tourists for sitting on nesting turtles
